Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-remifentanil versus sevoflurane anesthesia in breast cancer surgery
ACTRN12611000301965Phase 4Not yet recruiting
- Sponsor
- Jie Ae Kim
- Start
- Mar 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol, remifentanil and sevoflurane in breast cancer (2 arms), sponsored by Jie Ae Kim. Primary endpoints: Regulatory T-cell subset in peripheral blood and Activated T-cell panel in peripheral blood. Planned start Mar 2011; status: not yet recruiting.
02
Drugs
propofolremifentanilsevoflurane
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12611000301965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000301965.